At menopause, weight, exercise, education, income play big roles in metabolic risks

December 16, 2015

CLEVELAND, Ohio (December 16, 2015)--At midlife, overweight and obesity, lack of exercise, less education, and low income put women at much higher risk of having metabolic syndrome, the cluster of conditions predisposes people to diabetes and heart disease, shows a large study published today in Menopause, the journal of The North American Menopause Society.

The researchers from Yonsei University in Seoul and Hallym University in Chuncheon, Korea, analyzed four years of data from the Korean Genetic Epidemiologic Survey on some 1,200 healthy women 45 to 55 years old who did not use hormones and looked for characteristics that predisposed the women to having metabolic syndrome or developing it as they went through menopause.

Metabolic syndrome includes excess body fat around the waist, increased blood pressure, high blood sugar, and abnormal cholesterol levels. Weight gain and a higher risk of metabolic syndrome are known to be common at menopause. But what has not been as well understood is how much social and economic conditions and the transition through menopause influence that risk.

For the women overall in the study, transitioning through menopause or becoming postmenopausal (reaching or exceeding 1 year after their final period) during the study did not significantly increase the risk of metabolic syndrome. But for overweight, obese, sedentary, undereducated, and disadvantaged women, the picture was very different.

In contrast to normal-weight women, overweight women in the study had more than 4 times the risk and obese women more than 12 times risk of metabolic syndrome. Women who didn't exercise had a 1.6 times greater risk than exercisers. For the women who were in perimenopause, the time of irregular periods before menopause, those who were overweight had 3 times the risk of normal weight women for metabolic syndrome, and those who were obese had 9 times the risk. Overweight women who became postmenopausal during the study had 3 times and obese women 8.5 times greater risk than those with normal body weight. And postmenopausal women who did not exercise had a 1.6 times greater risk than high-level exercisers.

For women in the study who had less than 10 years of education, the risk of metabolic syndrome was 1.4 times greater than for more educated women, and the risk for low income women was 1.6 to 1.7 times greater than for wealthier women. Among the women who experienced menopause during the study, those who did not have more than a high-school education had 1.7 times the risk of better educated women. In addition, disadvantaged women who went through menopause during the study had 2.5 times the risk and middle-income women 2 times the risk of their wealthier counterparts.

"As women make the transition from regular cycles through the transition to menopause and after, it is more difficult to maintain a healthy weight, not just because of hormonal changes but also because of aging , less muscle mass, and life stressors, too. This study underscores how important it is to work hard to stave off weight gain as much as possible," says NAMS Executive Director JoAnn V. Pinkerton, MD, NCMP.

So what helps? "Decrease food intake and move more," she suggests. "If women continue to eat as they always have and don't increase their physical activity as their metabolism decreases, they are likely to gain weight."

The study data showed that at least some women heard the exercise message and increased their activity later on during the study. But much more needs to be done, and the authors called for emphasizing weight management and encouraging high levels of physical activity in women before menopausal changes occur and for policy measures that are sensitive to the health needs of economically disadvantaged women.
-end-
The article, "Role of social determinants and lifestyle on women's metabolic risk during the perimenopausal transition: results from a cohort study," will be published in the April 2016 print edition of Menopause.

Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field--including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education--makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit http://www.menopause.org.

The North American Menopause Society (NAMS)

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.